
Medicine and Health
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
Y. Du, R. Shi, et al.
Discover the groundbreaking research on h11B11, an ACE2-blocking monoclonal antibody that demonstrates exceptional efficacy in inhibiting SARS-CoV and SARS-CoV-2. Conducted by an expert team including Yanyun Du and Rui Shi, this study unveils promising therapeutic and preventive strategies against viral replication with minimal toxicity.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.